Royalty Pharma (RPRX) Dividend Coverage Ratio Growth (1y) (2020 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Dividend Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | -10.85% |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1.84% |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.65 Bn | 21.11 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.84% |
| Mar 31, 2026 | 45.50% |
| Dec 31, 2025 | -17.86% |
| Sep 30, 2025 | -50.15% |
| Jun 30, 2025 | -62.12% |
| Mar 31, 2025 | 6,145.62% |
| Dec 31, 2024 | -63.72% |
| Sep 30, 2024 | 562.75% |
| Jun 30, 2024 | -44.95% |
| Mar 31, 2024 | -100.88% |
| Dec 31, 2023 | 259.24% |
| Sep 30, 2023 | -31.27% |
| Jun 30, 2023 | -11.44% |
| Mar 31, 2023 | 310.81% |
| Dec 31, 2022 | -7,792.29% |
| Sep 30, 2022 | 222.74% |
| Jun 30, 2022 | 81.18% |
| Mar 31, 2022 | 193.46% |
| Dec 31, 2021 | 81.72% |
| Sep 30, 2021 | -67.04% |